A Brief History of Immunotherapy. CAR-T, t-cell augmentation, and immunotherapy in general over the past decade. We will talk about why is this approach so compelling, and what its limitations have been to date.
Special guests:
Chief Executive Officer
Assistant Professor, Department of Immuno-Oncology
Assistant Professor, Department of Pediatrics
City Of Hope
This series is brought to you ad-free by Adaptive Biotechnologies
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
